Bölüm "Uludag University Faculty of Medicine, Department of Pediatric Infectious DiseasesBursa, Turkey; Uludag University Faculty of Medicine, Department of Pediatric HematologyBursa, Turkey; Uludag University Faculty of Medicine, Department of Medical MycologyBursa, Turkey; Uludag University Faculty of Medicine, Department of NeonatologyBursa, Turkey; Uludag University Faculty of Medicine, Department of Pediatric OncologyBursa, Turkey; Celal Bayar University Faculty of Medicine, Department of Pediatric EndocrinologyManisa, Turkey" için listeleme

Toplam kayıt 1, listelenen: 1-1

    • Evaluation of Micafungin Use in Children [Çocuklarda Mikafungin Kullanımının Değerlendirilmesi] 

      Yeşil, E. and Çelebi, S. and Sezgin Evim, M. and Özer, A. and Turan, C. and Timur, D. and Çakır, S.Ç. and Bülbül, B. and Ener, B. and Güneş, A.M. and Köksal, N. and Özkan, H. and Sevinir, B. and Düzcan Kilimci, D. and Hacımustafaoğlu, M. (NLM (Medline), 2020)
      Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis. The aim ...